Q3 2019 Agios Pharmaceuticals Inc Earnings Call Transcript
Good morning and welcome to Agios' Third Quarter 2019 Conference Call. (Operator Instructions) Please be advised this call is being recorded at Agios' request.
I would now like to turn the call over to Kendra Adams, Vice President, External Communications and Investor Relations.
Thank you, Kevin. Good morning, everyone, and welcome to Agios' Third Quarter 2019 Conference Call. You can access slides for today's call by going to the Investors section of our website, agios.com.
With me on the call today with prepared remarks are Dr. Jackie Fouse, our Chief Executive Officer; Dr. Chris Bowden, our Chief Medical Officer; Darrin Miles, our Senior Vice President of U.S. Commercial and Global Marketing; and Andrew Hirsch, our Chief Financial Officer and Head of Corporate Development. Dr. Scott Biller, our Chief Scientific Officer, will also be available for Q&A.
Before we get started, I would like to remind everyone that some of the statements we make on
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |